Literature DB >> 18262552

Proinflammatory cytokines increase hepatocellular carcinoma cells thermotolerance: evidence of how local inflammation may negatively impact radiofrequency ablation local control rates.

Wade G Douglas1, Yangping Wang, John F Gibbs, Erin Tracy, Boris Kuvshinoff, Kristin Huntoon, Heinz Baumann.   

Abstract

BACKGROUND: Hepatocellular carcinomas (HCC) associated with inflammation that undergo radiofrequency ablation (RFA) appear to have poorer local control rates. Little is known of how mediators of inflammation influence HCC cellular thermotolerance, which in part is mediated by heat shock protein 70 (HSP70). This study determines how inflammatory mediators affect cellular thermotolerance and provides insight into how associated inflammation may impact HCC RFA local control rates.
METHODS: HepG2 cell lines were cultured in control medium (CM) or CM containing conditioned medium of endotoxin-activated macrophage (CMM). Serial dilutions of CMM established microenvironments approximating low, medium, and high CMM. All groups underwent a heat shock challenge (HSC) at 45 degrees C for 10 min. Western blot, Northern blot, densitometric analysis, along with thymidine and clonogenic assays determined how inflammation influenced multiple biological endpoints.
RESULTS: Cells cultured in low CMM expressed significantly more HSP70 RNA and protein compared with control cells after HSC. The cells also had a higher proliferative and survival rate after HSC compared with control cells. Medium CMM cultured cells had no significant difference in HSP70 RNA and protein production or proliferation and survival rates after HSC, compared with CM cultured cells. AT high CMM, the inhibitory effects of inflammatory mediators prevailed and all of the measured endpoints were significantly less compared with CM cultured cells.
CONCLUSIONS: This study demonstrates that inflammation can alter the responsiveness of HCC cells to a HSC in a dose-dependent manner. This study supports the clinical observation that HCC associated with chronic inflammation have worse RFA local control rates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18262552      PMCID: PMC2610809          DOI: 10.1016/j.jss.2007.09.012

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  20 in total

1.  Overexpression of the heat shock protein 70 confers protection against oxidative injury in HEPG2 cells.

Authors:  N Hosoi; H Itoh; K Koyama; Y Tashima
Journal:  Transplant Proc       Date:  2002-11       Impact factor: 1.066

2.  Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome.

Authors:  H M Beere; B B Wolf; K Cain; D D Mosser; A Mahboubi; T Kuwana; P Tailor; R I Morimoto; G M Cohen; D R Green
Journal:  Nat Cell Biol       Date:  2000-08       Impact factor: 28.824

3.  Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth.

Authors:  J Song; M Takeda; R I Morimoto
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

4.  Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis.

Authors:  Claudia Drucker; Wolfram Parzefall; Olga Teufelhofer; Michael Grusch; Adolf Ellinger; Rolf Schulte-Hermann; Bettina Grasl-Kraupp
Journal:  Carcinogenesis       Date:  2005-08-04       Impact factor: 4.944

5.  Haptoglobin, an inflammation-inducible plasma protein.

Authors:  Y Wang; E Kinzie; F G Berger; S K Lim; H Baumann
Journal:  Redox Rep       Date:  2001       Impact factor: 4.412

6.  Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma.

Authors:  M M Bilimoria; G Y Lauwers; D A Doherty; D M Nagorney; J Belghiti; K A Do; J M Regimbeau; L M Ellis; S A Curley; I Ikai; Y Yamaoka; J N Vauthey
Journal:  Arch Surg       Date:  2001-05

7.  Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.

Authors:  M Nishikawa; S Nishiguchi; S Shiomi; A Tamori; N Koh; T Takeda; S Kubo; K Hirohashi; H Kinoshita; E Sato; M Inoue
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

8.  mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.

Authors:  S Shapiro; V Gershtein; N Elias; E Zuckerman; N Salman; N Lahat
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

9.  Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines.

Authors:  Gregory M Loewen; Erin Tracy; Frédéric Blanchard; Dongfeng Tan; Jihnhee Yu; Sameera Raza; Sei-Ichi Matsui; Heinz Baumann
Journal:  BMC Cancer       Date:  2005-11-04       Impact factor: 4.430

10.  Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.

Authors:  X G Fan; W E Liu; C Z Li; Z C Wang; L X Luo; D M Tan; G L Hu; Z Zhang
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

View more
  1 in total

Review 1.  Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis.

Authors:  Valli De Re; Anna Rossetto; Alessandro Rosignoli; Elena Muraro; Vito Racanelli; Maria Lina Tornesello; Aron Zompicchiatti; Alessandro Uzzau
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.